2002年获北京大学医学部感染疾病专业临床博士学位,后在北京大学第一医院感染疾病科工作至今。一直致力于肝脏疾病和感染性疾病的临床和科研。2012年-2013年国家公派留学至美国国立卫生研究院酒精依赖和酒精中毒研究所(NIH、NIAAA)的肝病实验室。曾获“2011年度北京市青年优秀医师”、2017年度第一届“国之名医-青年新锐”奖。担任北京大学第一医院肝病中心学术秘书;北京大学第一医院罕见病专家委员会委员;北京医师协会感染医师分会常务理事兼总干事;北京医学会感染病分会委员兼学术秘书;北京预防医学会感染病分会委员;北京市医疗鉴定专家库专家;教育部学位论文评审专家以及多家杂志编委。
发表论文:
1,Case report: Wallerian degeneration: The innate-immune response to adult-onset Still’s disease peripheral nerve injury。Frontiers in Neurology。10.3389/fneur.2022.1016393
2, .Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway.Int J Biol Sci. 2022 Mar 6;18(6):2317-2328.
3,Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice.Hepatobiliary Surg Nutr. 2022 Apr;11(2):199-211.
4,Asystematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—Apossible reference for coronavirus disease‐19 treatment option. J Med Virol. 2020.92(6):556-563.
5,Organ-protective Effect of Angiotensin-converting Enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol.2020.92(7):726-730
6,Reporting of all cardiac medications and their outcome in COVID - 19.J Med Virol.2020.Apr 13:10.1002/jmv.25868.(dio:10.1002/jmv.25868)
7,Shear wave elastography may be more sensitive and more precise than transient elastograpgy in predicting significant fibrosis in CHB patients: A prospective comparative study.World Journal of Clinical Cases. 2020 Sep 6;8(17):3730-3742.
8,B lymphocytes-Mediated Humoral Immunity in the pathogenesis of Chronic Hepatitis B infection.Liver Research. https://doi.org/10.1016/j.livres.2020.07.001
9, RIPK3-Mediated Necroptosis and Neutrophil Infiltration Are Associated with Poor Prognosis in Patients with Alcoholic Cirrhosis. Journal of Immunology Research. 2018 Nov 25; 2018:1509851.
10, Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage. Mediators of Inflammation. 2017:3526903.
1,基础慢性肝脏疾病对接受免疫检查点抑制剂治疗的肿瘤患者的疗效及安全性的影响。临床肝胆病杂志。2022.38(11):2457-2461.
2,我国慢性丙型病毒性肝炎筛查与治疗的医疗费用. 中国药物经济学。2021.16(12):5-10
3,干扰素治疗1-6岁慢乙肝儿童的抗病毒疗效及影响因素分析。国际病毒学杂志。2020.27(3):
4,58 例药物超敏反应综合征、成人Still 病、噬血细胞性淋巴组织细胞增多症合并肝损伤临床特征分析.临床肝胆病杂志。2020.36(10):2253-2257.
5,全身炎症反应导致肝损伤的临床特点和机制研究现状.国际病毒学杂志 2019.26(5) :354-357.
6,新型人纤维蛋白原治疗获得性纤维蛋白原减少症的随机、双盲、阳性药物平行对照、多中心临床试验。中国临床药理学杂志。2019.35(10):953-956
7,肝细胞FcRn,治疗药物性肝损伤的曙光。肝脏。2018.3:199-200
8,过氧化物酶体增殖物激活受体α在对乙酰氨基酚肝损伤的研究进展.安徽医药。2018.22(12):2279-82
9,12例IgG4相关硬化性胆管炎临床病例特点分析。临床肝胆病杂志。2018.34(6):1253-8